Regenerative aesthetic medicine was shaped by decades of progress in human cell culture, biomaterials, and translational biotechnology. Ruimei exists to bring those breakthroughs into something you can actually experience.
Tissue Regeneration Labora-tory established, translating biomaterial research into clinical aesthetic solutions.
Lausanne, Switzerland (EPFL Innovation Park) and Shen-zhen, China — dual engines of discovery and scale.
RegeneColla™ Human Type I Collagen and RegeneExo™ Stem Cell Exosomes — both GMP-manufactured.
ISO Class 7 / Class 10,000 cleanroom production with rigorous batch-to-batch quality release protocols.
In 2023, we established our Tissue Regeneration Laboratory to translate rigorous biomaterial research into real-world aesthetic solutions — built around two core platforms: RegeneColla™ (human Type I collagen) and RegeneExo™ (stem cell–derived exosomes). The best aesthetic outcomes come from working with the body, not against it.
Our Swiss R&D base anchors Ruimei's scientific foundation within one of the world's most prestigious academic and biotech ecosystems. Lausanne drives our biomaterial research, formulation precision, and the global quality standards that define every product we release.
Our Shenzhen hub integrates GMP manufacturing, scale-up engineering, and Asia-facing clinical translation — converting Swiss-grade research into market-ready regenerative solutions at speed and consistent quality. ISO Class 7 cleanroom production with rigorous batch-to-batch release protocols.
"Treatments that feel refined, look natural, and are engineered for long-term skin health."
ENTER YOUR INFORMATION, AND OUR DEDICATED TEAM WILL CONTACT YOU SHORTLY
